Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies: John Schoellerman

John Schoellerman has joined Oxford Nanopore Technologies as senior vice president of corporate development and investment. Previously, he was managing director and head of medtech at Lazard, and before that, he worked in healthcare investment banking at JP Morgan. Schoellerman holds a BA from Harvard University and an MBA from INSEAD.

The Scan

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.